Anticancer Property of Bromelain With Therapeutic Potential in Malignant Peritoneal Mesothelioma

@article{Pillai2013AnticancerPO,
  title={Anticancer Property of Bromelain With Therapeutic Potential in Malignant Peritoneal Mesothelioma},
  author={Krishna Kumar Sreedharan Pillai and Javed Akhter and Terence C Chua and David L Morris},
  journal={Cancer Investigation},
  year={2013},
  volume={31},
  pages={241 - 250}
}
  • Krishna Kumar Sreedharan Pillai, Javed Akhter, +1 author David L Morris
  • Published 2013
  • Medicine
  • Cancer Investigation
  • Bromelain is a mixture of proteolytic enzymes that is capable of hydrolyzing glycosidic linkages in glycoprotein. Glycoprotein's are ubiquitously distributed throughout the body and serve a variety of physiologic functions. Faulty glycosylation of proteins may lead to cancer. Antitumor properties of bromelain have been demonstrated in both, in vitro and in vivo studies, along with scanty anecdotal human studies. Various mechanistic pathways have been proposed to explain the anticancer… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 22 CITATIONS, ESTIMATED 70% COVERAGE

    Targeting MUC16 in Cancer Therapy

    VIEW 3 EXCERPTS
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2014
    2020

    CITATION STATISTICS

    • 1 Highly Influenced Citations

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 150 REFERENCES

    Bromelain-induced apoptosis in GI-101A breast cancer cells.

    VIEW 2 EXCERPTS

    Bromelain: biochemistry, pharmacology and medical use

    VIEW 2 EXCERPTS